Len Pattenden

Head of Biotherapeutics Development & Drug Supply
Cancer Research UK 
Len Pattenden
Len leads the Biotherapeutics Development Unit (BDU) which is a CRUK GMP facility. The BDU team are accountable for regulated manufacture of biological drugs within the CDD portfolio. Len joined CDD in 2018 and has more than 20 years’ experience across academia and industry in drug and process development, clinical supply and manufacture. He has worked for Adaptimmune, Lonza, Koch Industries and CSL, with a track record of process development for industrialisation including pharmaceutical phases 1–3 and delivery to the market. Len has a PhD in drug development and post-doctoral experience in protein chemistry, and founded Australia’s first synthetic biology lab.

Sessions

No data was found